Back to top

RadNet (RDNT) Surges: Stock Moves 21.8% Higher
May 12, 2014

Read MoreHide Full Article
RadNet, Inc. (RDNT - Free Report) was a big mover last session, as the company saw its shares rise by almost 22% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up over 59% in the past one-month time frame.

This medical laboratories & research company has seen one positive estimate revision over the last 30 days and its Zacks Consensus Estimate moved higher over the same time frame, suggesting that more solid trading could be ahead for RadNet. So make sure to keep an eye on this stock going forward to see if this recent move higher can turn into more strength down the road.

RadNet currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the medical sector include Akorn, Inc. (AKRX - Free Report) , ANI Pharmaceuticals, Inc. (ANIP - Free Report) and Aastrom Biosciences, Inc. . All these stocks carry a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

RadNet, Inc. (RDNT) - free report >>

Akorn, Inc. (AKRX) - free report >>

ANI Pharmaceuticals, Inc. (ANIP) - free report >>

More from Zacks Tale of the Tape

You May Like